For: | Fang XF, Hou ZB, Dai XZ, Chen C, Ge J, Shen H, Li XF, Yu LK, Yuan Y. Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer. World J Gastroenterol 2013; 19(15): 2331-2339 [PMID: 23613626 DOI: 10.3748/wjg.v19.i15.2331] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i15/2331.htm |
Number | Citing Articles |
1 |
J. Brocato, M. Costa. SATB1 and 2 in colorectal cancer. Carcinogenesis 2015; 36(2): 186 doi: 10.1093/carcin/bgu322
|
2 |
Anna E. Kowalczyk, Janusz Godlewski, Bartlomiej E. Krazinski, Jolanta Kiewisz, Agnieszka Sliwinska-Jewsiewicka, Przemyslaw Kwiatkowski, Bartosz Pula, Piotr Dziegiel, Jacek Janiszewski, Piotr M. Wierzbicki, Zbigniew Kmiec. Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues. Tumor Biology 2015; 36(6): 4441 doi: 10.1007/s13277-015-3084-0
|
3 |
Ivana Kristina Delic Jukic, Sandra Kostic, Natalija Filipovic, Larissa Gudelj Ensor, Marijeta Ivandic, Jozefina Josipa Dukic, Marija Vitlov Uljevic, Lejla Ferhatovic Hamzic, Livia Puljak, Katarina Vukojevic. Changes in expression of special AT-rich sequence binding protein 1 and phosphatase and tensin homologue in kidneys of diabetic rats during ageing. Nephrology Dialysis Transplantation 2018; 33(10): 1734 doi: 10.1093/ndt/gfy003
|
4 |
Bo Huang, Fei Xiong, Siwang Wang, Xianping Lang, Xiaodong Wang, Hongli Zhou. Effect of SATB1 silencing on the proliferation, invasion and apoptosis of TE-1 esophageal cancer cells. Oncology Letters 2017; 13(5): 2915 doi: 10.3892/ol.2017.5854
|
5 |
Anja Frömberg, Kurt Engeland, Achim Aigner. The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumors. Cancer Letters 2018; 417: 96 doi: 10.1016/j.canlet.2017.12.031
|
6 |
Jing-huan Lv, Feng Wang, Ming-hong Shen, Xuan Wang, Xiao-jun Zhou. SATB1 expression is correlated with β-catenin associated epithelial–mesenchymal transition in colorectal cancer. Cancer Biology & Therapy 2016; 17(3): 254 doi: 10.1080/15384047.2016.1139239
|
7 |
Li-jun Mao, Jie Zhang, Ning Liu, Li Fan, Dong-rong Yang, Bo-xin Xue, Yu-xi Shan, Jun-nian ZHENG. Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis. Tumor Biology 2015; 36(11): 9073 doi: 10.1007/s13277-015-3658-x
|
8 |
Zheng Chen, Zengliang Li, Wei Li, Yang Zong, Yi Zhu, Yi Miao, Zekuan Xu. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation. Digestive Diseases and Sciences 2015; 60(11): 3304 doi: 10.1007/s10620-015-3759-9
|
9 |
Bo Huang, Hongli Zhou, Siwang Wang, Xian Ping Lang, Xiaodong Wang. Effect of silencing SATB1 on proliferation, invasion and apoptosis of A549 human lung adenocarcinoma cells. Oncology Letters 2016; 12(5): 3818 doi: 10.3892/ol.2016.5179
|
10 |
Anja Frömberg, Michael Rabe, Henry Oppermann, Frank Gaunitz, Achim Aigner. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-016-3006-6
|
11 |
Wenfeng Liu, Meng Zhang, Xiaojie Du, Min Zhang, Weiling Wang, Zhiying Zhang. MicroRNA-153 Restrains Cell Metastasis and Epithelial–Mesenchymal Transition in Cervical Carcinoma by Targeting SATB1 and Regulating Wnt/β-Catenin Pathway. Journal of Biomedical Nanotechnology 2024; 20(2): 398 doi: 10.1166/jbn.2024.3761
|
12 |
DARIUSZ GRZANKA, MACIEJ GAGAT, MAGDALENA IZDEBSKA, ANDRZEJ MARSZAŁEK. Expression of special AT-rich sequence-binding protein 1 is an independent prognostic factor in cutaneous T-cell lymphoma. Oncology Reports 2015; 33(1): 250 doi: 10.3892/or.2014.3597
|
13 |
Yanli Feng, Xin Wang, Quanyi Wang. Expression of SATB1 and E-cad in tissues of patients with endometrial carcinoma and the relationship with clinicopathological features. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5954
|
14 |
Jinmyung Jung, Jonathan Wren. Characterizing therapeutic signatures of transcription factors in cancer by incorporating profiles in compound treated cells. Bioinformatics 2021; 37(7): 1008 doi: 10.1093/bioinformatics/btaa765
|
15 |
Charlotta Hedner, Alexander Gaber, Dejan Korkocic, Björn Nodin, Mathias Uhlén, Eugenia Kuteeva, Henrik Johannesson, Karin Jirström, Jakob Eberhard. SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma. Virchows Archiv 2014; 465(6): 649 doi: 10.1007/s00428-014-1667-6
|
16 |
Anja Frömberg, Michael Rabe, Achim Aigner. Multiple effects of the special AT‐rich binding protein 1 (SATB1) in colon carcinoma. International Journal of Cancer 2014; 135(11): 2537 doi: 10.1002/ijc.28895
|
17 |
Yan Zhang, Haibo Wu, Man Zhang, Yali Jiang, Weiwei Zhuo, Yong Zhang, Song Hua. Nicotinamide induces apoptosis of F9 mouse teratocarcinoma stem cells by downregulation of SATB1 expression. Tumor Biology 2015; 36(6): 4339 doi: 10.1007/s13277-015-3073-3
|
18 |
Yi Zhang, Xiuyun Tian, Hong Ji, Xiaoya Guan, Wei Xu, Bin Dong, Min Zhao, Meng Wei, Chunxiang Ye, Yuan Sun, Xiaosun Yuan, Chen Yang, Chunyi Hao, Masaru Katoh. Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer. PLoS ONE 2014; 9(6): e100413 doi: 10.1371/journal.pone.0100413
|
19 |
Krishna P. Sunkara, Gaurav Gupta, Philip M. Hansbro, Kamal Dua, Mary Bebawy. Functional relevance of SATB1 in immune regulation and tumorigenesis. Biomedicine & Pharmacotherapy 2018; 104: 87 doi: 10.1016/j.biopha.2018.05.045
|
20 |
Sam Al‐Sohaily, Christopher Henderson, Christina Selinger, Laurent Pangon, Eva Segelov, Maija R. J. Kohonen‐Corish, Janindra Warusavitarne. Loss of special AT‐rich sequence‐binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer. Histopathology 2014; 65(2): 155 doi: 10.1111/his.12295
|
21 |
Gulsum S. Yalcin, Mehmet A. Gonultas, Sema Hucumenoglu, Gulcin Simsek, Mevlut R. Pekcici. SATB1 Expression of Colorectal Adenomatous Polyps is Higher than that of Colorectal Carcinomas. Applied Immunohistochemistry & Molecular Morphology 2020; 28(7): 532 doi: 10.1097/PAI.0000000000000791
|